Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000004

CHIEF FINANCIAL OFFICER acquired 14,184 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-07 Option exercise +14,184 $2.45 $34,751 191,100 D
Derivatives
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-07 Option exercise · Stock Options −14,184 $2.45 $34,751 836,567 D
Loading xslF345X05/form4-01072026_090120.xml…